ArticleWorld journal of oncology2026

Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction.

Ahmad Alwazzan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.